Design of Randomized, double ‐blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE‐SPECT ESUS)

International Journal of Stroke,Volume 10, Issue 8, Page 1309-1312, December 2015.
Source: International Journal of Stroke - Category: Neurology Source Type: research
More News: Pradaxa | SPECT | Stroke